Viewing Study NCT05298020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:04 AM
Study NCT ID: NCT05298020
Status: UNKNOWN
Last Update Posted: 2022-03-28
First Post: 2022-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
Sponsor: The Affiliated Hospital of Xuzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module